Chemotherapy with stem cell transplantation is more effective than immunotherapy in sporadic late onset nemaline myopathy with monoclonal gammopathy
Open Access
- 24 January 2018
- journal article
- letter
- Published by Springer Science and Business Media LLC in Bone Marrow Transplantation
- Vol. 53 (7), 895-899
- https://doi.org/10.1038/s41409-017-0080-6
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Amyloidosis: Pathogenesis and New Therapeutic OptionsJournal of Clinical Oncology, 2011
- Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38α MAPK pathwayProceedings of the National Academy of Sciences of the United States of America, 2010
- Chemotherapy is successful in sporadic late onset nemaline myopathy (SLONM) with monoclonal gammopathyMuscle & Nerve, 2009
- Sporadic late onset nemaline myopathy responsive to IVIg and immunotherapyMuscle & Nerve, 2009
- Adult nemaline myopathy with trabecular muscle fibersMuscle & Nerve, 2009
- STEM CELL TRANSPLANTATION IN A PATIENT WITH LATE-ONSET NEMALINE MYOPATHY AND GAMMOPATHYNeurology, 2008
- High-Dose Melphalan versus Melphalan plus Dexamethasone for AL AmyloidosisThe New England Journal of Medicine, 2007
- Autologous peripheral blood stem cell transplantation for POEMS syndromeNeurology, 2006
- Sporadic late onset nemaline myopathyNeurology, 2005
- Late-onset rod myopathy associated with monoclonal gammopathyNeuromuscular Disorders, 1993